In the newsNews in mediaGenerate your reports faster

In the news | 6th Oct 2021

The Rise of Predictive Modeling and Machine Learning in Biopharma

The biopharma industry may have been slow to embrace digital technologies, but it’s catching up fast. The innovation we’re seeing in predictive modeling and machine learning could truly revolutionize the entire lifecycle of drug discovery and development. Take a look at this piece by Danaher VP Kevin Chance in PharmaTimes, exploring the latest advances and discussing how groundbreaking technologies could transform our industry in the months and years to come: PharmaTimes Magazine

The biopharma industry may have been slow to embrace digital technologies, but it’s catching up fast. The innovation we’re seeing in predictive modeling and machine learning could truly revolutionize the entire lifecycle of drug discovery and development. Take a look at this piece by Danaher VP Kevin Chance in PharmaTimes, exploring the latest advances and discussing how groundbreaking technologies could transform our industry in the months and years to come: PharmaTimes Magazine